Assessment of physical performance using the 6-minute walk test in children receiving treatment for cancer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

BACKGROUND: The study of physical performance in children with cancer is emerging as an important variable in symptom research. Studies have shown that children with cancer experience deficits in physical performance during treatment that may be present years after therapy. OBJECTIVE: The aim of this study was to determine if distance on the 6-minute walk test (6MWT) changed in children during the first 3 cycles of cancer treatment and to compare the distances walked with healthy norms. METHODS: This is a secondary data analysis of 19 boys and 10 girls, aged 6 to 17 years, who were newly diagnosed with cancer and were part of a larger study that measured changes in fatigue and physical performance during the first 3 cycles of chemotherapy. Participants performed the 6MWT between days 15 and 29 of the first and third cycles of chemotherapy. RESULTS: Pediatric cancer patients did not have a significant change in the distance walked at cycle 3 of chemotherapy compared with cycle 1. When compared with 2 different normative data sets for healthy children, most children with cancer performed significantly below their peers. CONCLUSIONS: Children had poor strength and endurance after 3 cycles of chemotherapy even when their disease was responding to treatment. Interventions are needed to promote rehabilitation and maintenance of physical performance, as both are important to quality of life and ongoing child development. IMPLICATIONS FOR PRACTICE: Children receiving cancer treatment who are ambulatory may appear to be functioning normally but are in fact severely deconditioned compared with their healthy peers.

Original languageEnglish (US)
Pages (from-to)E9-E16
JournalCancer Nursing
Volume36
Issue number5
DOIs
StatePublished - Sep 1 2013

Fingerprint

Neoplasms
Drug Therapy
Therapeutics
Child Development
Walk Test
Fatigue
Rehabilitation
Maintenance
Quality of Life
Pediatrics
Research

Keywords

  • 6-Minute walk test
  • Children with cancer
  • Physical performance

Cite this

@article{0a375e3a8e5747348f358b1b842a8a4a,
title = "Assessment of physical performance using the 6-minute walk test in children receiving treatment for cancer",
abstract = "BACKGROUND: The study of physical performance in children with cancer is emerging as an important variable in symptom research. Studies have shown that children with cancer experience deficits in physical performance during treatment that may be present years after therapy. OBJECTIVE: The aim of this study was to determine if distance on the 6-minute walk test (6MWT) changed in children during the first 3 cycles of cancer treatment and to compare the distances walked with healthy norms. METHODS: This is a secondary data analysis of 19 boys and 10 girls, aged 6 to 17 years, who were newly diagnosed with cancer and were part of a larger study that measured changes in fatigue and physical performance during the first 3 cycles of chemotherapy. Participants performed the 6MWT between days 15 and 29 of the first and third cycles of chemotherapy. RESULTS: Pediatric cancer patients did not have a significant change in the distance walked at cycle 3 of chemotherapy compared with cycle 1. When compared with 2 different normative data sets for healthy children, most children with cancer performed significantly below their peers. CONCLUSIONS: Children had poor strength and endurance after 3 cycles of chemotherapy even when their disease was responding to treatment. Interventions are needed to promote rehabilitation and maintenance of physical performance, as both are important to quality of life and ongoing child development. IMPLICATIONS FOR PRACTICE: Children receiving cancer treatment who are ambulatory may appear to be functioning normally but are in fact severely deconditioned compared with their healthy peers.",
keywords = "6-Minute walk test, Children with cancer, Physical performance",
author = "Hooke, {Mary C.} and Garwick, {Ann W.} and Neglia, {Joseph P.}",
year = "2013",
month = "9",
day = "1",
doi = "10.1097/NCC.0b013e31829f5510",
language = "English (US)",
volume = "36",
pages = "E9--E16",
journal = "Cancer Nursing",
issn = "0162-220X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Assessment of physical performance using the 6-minute walk test in children receiving treatment for cancer

AU - Hooke, Mary C.

AU - Garwick, Ann W.

AU - Neglia, Joseph P.

PY - 2013/9/1

Y1 - 2013/9/1

N2 - BACKGROUND: The study of physical performance in children with cancer is emerging as an important variable in symptom research. Studies have shown that children with cancer experience deficits in physical performance during treatment that may be present years after therapy. OBJECTIVE: The aim of this study was to determine if distance on the 6-minute walk test (6MWT) changed in children during the first 3 cycles of cancer treatment and to compare the distances walked with healthy norms. METHODS: This is a secondary data analysis of 19 boys and 10 girls, aged 6 to 17 years, who were newly diagnosed with cancer and were part of a larger study that measured changes in fatigue and physical performance during the first 3 cycles of chemotherapy. Participants performed the 6MWT between days 15 and 29 of the first and third cycles of chemotherapy. RESULTS: Pediatric cancer patients did not have a significant change in the distance walked at cycle 3 of chemotherapy compared with cycle 1. When compared with 2 different normative data sets for healthy children, most children with cancer performed significantly below their peers. CONCLUSIONS: Children had poor strength and endurance after 3 cycles of chemotherapy even when their disease was responding to treatment. Interventions are needed to promote rehabilitation and maintenance of physical performance, as both are important to quality of life and ongoing child development. IMPLICATIONS FOR PRACTICE: Children receiving cancer treatment who are ambulatory may appear to be functioning normally but are in fact severely deconditioned compared with their healthy peers.

AB - BACKGROUND: The study of physical performance in children with cancer is emerging as an important variable in symptom research. Studies have shown that children with cancer experience deficits in physical performance during treatment that may be present years after therapy. OBJECTIVE: The aim of this study was to determine if distance on the 6-minute walk test (6MWT) changed in children during the first 3 cycles of cancer treatment and to compare the distances walked with healthy norms. METHODS: This is a secondary data analysis of 19 boys and 10 girls, aged 6 to 17 years, who were newly diagnosed with cancer and were part of a larger study that measured changes in fatigue and physical performance during the first 3 cycles of chemotherapy. Participants performed the 6MWT between days 15 and 29 of the first and third cycles of chemotherapy. RESULTS: Pediatric cancer patients did not have a significant change in the distance walked at cycle 3 of chemotherapy compared with cycle 1. When compared with 2 different normative data sets for healthy children, most children with cancer performed significantly below their peers. CONCLUSIONS: Children had poor strength and endurance after 3 cycles of chemotherapy even when their disease was responding to treatment. Interventions are needed to promote rehabilitation and maintenance of physical performance, as both are important to quality of life and ongoing child development. IMPLICATIONS FOR PRACTICE: Children receiving cancer treatment who are ambulatory may appear to be functioning normally but are in fact severely deconditioned compared with their healthy peers.

KW - 6-Minute walk test

KW - Children with cancer

KW - Physical performance

UR - http://www.scopus.com/inward/record.url?scp=84883264202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883264202&partnerID=8YFLogxK

U2 - 10.1097/NCC.0b013e31829f5510

DO - 10.1097/NCC.0b013e31829f5510

M3 - Article

C2 - 23963198

AN - SCOPUS:84883264202

VL - 36

SP - E9-E16

JO - Cancer Nursing

JF - Cancer Nursing

SN - 0162-220X

IS - 5

ER -